TauRx Therapeutics @TauRx Twitter profile

Last Seen Profiles

@kUJRycYEhv2wQOL

@abbas_n13

@komayu06

@TaitoCorp

@GageDickens

@NMDC_DM

@OrdinalMaxiBiz

@ninxcartz

@MaryJan06360294

@MelodicFuego

@L3VITICUS1999

@5F55F5

@Dagen

@sydney_parrish

@Scarlett__Mag

@RouxFK

@9_lapis_

@GremmarWarden

@EugeneGlushkov

@MariePace51

@astronoises

@bartxalaparta

@bblivery

@foolsroom

@minyo555

@Motinepupu

@ACIWorld

@stwmaniax

@santiago_ppart

@LelloMmassy

@SuLisa87

@amepi_man

@AsSa66986762

@ArthurJRegner

@_kimleader_

TauRx Therapeutics

@TauRx

7 months

Professor Claude Wischik is now presenting TauRx’s 24 month results at #ADPD2024 .

9

5

20

TauRx Therapeutics

@TauRx

4 years

Thank you @AlzheimerEurope ! We are very grateful for your virtual hospitality today and we hope that all the attendees gained something from the session. We look forward to keeping the discussions going as all research in this field progresses #dementia #targetingtau #tau

Alzheimer Europe

@AlzheimerEurope

4 years

This afternoon @TauRx and BrainMind are launching educational materials explaining the role of #tau in #Alzheimer 's disease, at a meeting with @AlzheimerEurope and our members

0

4

13

0

6

16

TauRx Therapeutics

@TauRx

7 months

Professor Claude Wischik, TauRx Co-Founder, CEO and Executive Chairman has presented the 24-month #Lucidity trial data at #ADPD2024 . 🔗 Read more here: #TauRx #ClinicalTrials #NeurodegenerativeDiseases

This link will take you to a page that’s not on LinkedIn

lnkd.in

5

3

14

TauRx Therapeutics

@TauRx

3 years

Evidence suggests that when people with dementia and their families are well prepared and supported, initial feelings of shock, anger and grief are balanced by a sense of reassurance and empowerment #WorldAlzMonth #KnowDementia #KnowAlzheimer @AlzDisInt @GtDiagnostics

0

5

13

TauRx Therapeutics

@TauRx

4 years

Pleased to share the publication of our most recent paper in JAD. Our latest findings give further encouragement that our phase 3 Alzheimer's disease trial will bring us a step closer to effective treatment for millions currently more vulnerable than ever.

0

4

14

TauRx Therapeutics

@TauRx

8 years

Phase 3 Results for TauRx’s LMTX® trial in Alzheimer’s disease reported at AAIC #AAIC16

1

13

TauRx Therapeutics

@TauRx

4 years

This #WorldAlzheimersMonth we have seen the launch of our new educational illustrations. Education underpins the acceptance of new ideas in established scientific, medical and patient communities, and we're excited to keep sharing our #Science #letstalkaboutdementia #Alzheimers

0

3

13

TauRx Therapeutics

@TauRx

3 years

The @TauRx team had a great time participating in #ScotMemWalk @AlzScot raising money for #Alzheimers and #dementia . #targetingtau #timefortauisnow #WorldAlzMonth #KnowDementia #KnowAlzheimers

0

2

10

TauRx Therapeutics

@TauRx

4 years

A big #ThankYou to @AlzDisInt , @alz_sg and all attendees at #ADI2020 . It has been a fantastic three days! TauRx are proud to have sponsored and presented our #tau -focused #research . If you missed us you can access our virtual booth for another month

1

12

TauRx Therapeutics

@TauRx

2 years

TauRx has raised USD119 million of additional funding following a successful warrants exercise triggered by the announcement of our Phase 3 LUCIDITY trial data.

1

2

10

TauRx Therapeutics

@TauRx

7 months

We are really excited to be at ADPD 2024 in Lisbon, Portugal! #ADPD2024

6

0

12

TauRx Therapeutics

@TauRx

7 months

Just minutes until we go live at #ADPD !

0

11

TauRx Therapeutics

@TauRx

4 years

New programme #HopeInTheAgeOfDementia from @AlzDisInt and @ITNProductions showcases how we are carrying out clinical trials with people living with #dementia to help find a solution to Alzheimer's disease. Watch Hope In The Age Of Dementia here.

ADI and ITN Productions present: Hope in the Age of Dementia (2020)

Alzheimer’s Disease International (ADI), the global voice on Dementia and ITN Productions Industry News have launched a news-style programme “Hope in the Age...

www.youtube.com

0

5

11

TauRx Therapeutics

@TauRx

3 years

Did you know, lifestyle has a profound impact on our #brainhealth ? - @brainhealthscot Lifestyle change is a top goal after the new year, so we asked the TauRx team to tell us their brain health #resolutions . Learn more about Brain Health Scotland:

0

3

11

TauRx Therapeutics

@TauRx

2 years

“Everybody believes and has the vision, and they all want to be able to make a difference.” Hear more from the TauRx UK leadership in our new video: #TargetingTau #TimeForTauIsNow #Alzheimers #dementia #TauRx

0

6

10

TauRx Therapeutics

@TauRx

4 years

Yesterday we were honoured to present the preview launch of this fantastic poster illustrating the role of #tau in #Alzheimers at a meeting kindly hosted by @AlzheimerEurope . Education will help patients, families and carers to better understand the latest #clinicalresearch

0

3

11

TauRx Therapeutics

@TauRx

2 years

By 2050, it’s expected that 139 million people will be living with #dementia , making the need for effective treatment ever more urgent. This week, TauRx is presenting information about our research targeting the tau pathology of #Alzheimer ’s disease at @ADIConference . #ADI2022

0

10

TauRx Therapeutics

@TauRx

3 years

During @AlzheimerEurope #31AEC Dr Sonya Miller, @TauRx Head of Medical Affairs, highlighted the challenges and lessons we encountered doing a late-stage clinical trial in the age of Covid. #targetingtau #timefortauisnow #dementia #Alzheimers

0

6

9

TauRx Therapeutics

@TauRx

4 years

Discussing the potential place of a #tau focused therapeutic in the treatment of #Alzheimer 's disease, Dr. Serge Gauthier chairs our #ADI2020 symposium Friday 11th December 12:50-13:50 GMT, join our live Q&A session, and visit our virtual booth.

0

4

9

TauRx Therapeutics

@TauRx

6 months

We're at @AlzResearchUK 's Research Conference today and tomorrow. A great couple of days ahead, strengthening collaborations with leading scientists and researchers! #ARUKConf24

1

10

TauRx Therapeutics

@TauRx

3 years

@TauRx is delighted to be featured in @TheScotsman , alongside @brainhealthscot and @craig_ritchie68 in this important article on the future of brain health. #targetingtau #timefortauisnow

Your guide to the future of brain health – and how research here in Scotland can play a vital role

With one in three people born today likely to develop dementia in their lifetime, brain health has never been more relevant.

www.scotsman.com

0

4

10

TauRx Therapeutics

@TauRx

3 years

Prof. Claude Wischik, Prof. Bjoern Schelter and Dr. Serge Gauthier discuss the future of #Alzheimers disease diagnostics in primary care and the need to detect AD as early as possible. #targetingtau #timefortauisnow #dementia #Alzheimers #tauprotein

0

3

10

TauRx Therapeutics

@TauRx

3 years

Today's #TauFacts is taken from a paper by @YoussraHilaly and the @TauRx team available here You can view our dedicated educational materials here #targetingtau #timefortauisnow #Alzheimers #dementia #tauprotein

0

5

10

TauRx Therapeutics

@TauRx

4 years

What is the future of #tau focused therapies in #Alzheimer 's? Watch this video to hear Professor Claude Wischik and Dr. Serge Gauthier's discussion ➡️ #dementia #lifesciences #research

0

4

9

TauRx Therapeutics

@TauRx

2 years

Alongside announcing results from our Phase 3 LUCIDITY trial, we’ve also appointed Dr. Richard Stefanacci as Chief Medical Officer. A global opinion leader in AD, he strengthens our team as we prepare to move our treatment through the regulatory process:

TauRx welcomes new Chief Medical Officer, Dr. Richard Stefanacci

TauRx named Dr. Richard Stefanacci, a US-based Internal Medicine physician and fellowship trained Geriatrician as Chief Medical Officer.

taurx.com

0

1

9

TauRx Therapeutics

@TauRx

4 years

"If you are sure of your data, then have the courage to believe in what you find, even if this differs from mainstream opinion" Prof. Claude Wischik CEO @TauRx and leader in Dementia research supports @dem_researcher Careers in Dementia Research week #NCW2021

0

2

6

TauRx Therapeutics

@TauRx

4 years

Our second paper in the space of a few days...the TauRx team has been very busy😀! There's been considerable progress in #tau -based research - we hope this takes us a few steps closer to the goal of finding a treatment for #Alzheimer 's & related diseases.

0

1

9

TauRx Therapeutics

@TauRx

4 years

It's encouraging to read the position statement. #COVID19 impact on our phase 3 #Clinicaltrial means we are working hard to protect data, adapt and continue progress. Industry support from @AlzheimerEurope @JeanGeorgesAE , recommending possible solutions, makes a +ve difference.

Alzheimer Europe

@AlzheimerEurope

4 years

#COVID19 has disrupted research into #dementia , undermining progress made. We call upon governments, funding bodies and research institutions to take urgent action to prioritise #dementia with the necessary resources, to help mitigate the damage.

0

35

34

0

4

9

TauRx Therapeutics

@TauRx

4 years

We are very grateful to @SussexUni and @SerpellLab for their input. Our previous encouraging trial results influenced our current phase 3 trial, now recruiting patients with mild to moderate #Alzheimers , to give us greater confidence in reaching primary endpoints. There is hope!

University of Sussex

@SussexUni

4 years

Led by Professor @Serpell1 in @SussexLifeSci , the @SerpellLab is working with pharmaceutical company @TauRx to find an effective treatment for #Alzheimers disease. 🔬 Read more about their incredible work on @NCUBtweets .

0

7

16

0

1

9

TauRx Therapeutics

@TauRx

3 years

2022 is set to be a pivotal year for TauRx as we progress ever closer to results of our current phase three clinical trial. Research provides hope to so many, and progress is vital in developing an effective treatment for Alzheimer’s disease #happynewyear

1

0

8

TauRx Therapeutics

@TauRx

4 years

Advances in diagnostics for #Alzheimers #dementia are crucial to ensure access to future treatments. This study by @karolinskainst supports #targetingtau for the treatment of AD, as it is again shown to have close correlation with symptom progression.

Karolinska Institutet

@karolinskainst

4 years

KI researchers Agneta Nordberg, Konstantinos Chiotis and others report in @MolPsychiatry that brain imaging for measuring the amount and spread of tau protein can be used to predict future memory loss in patients with #Alzheimers disease. @inKostasMind

0

10

9

0

1

8

TauRx Therapeutics

@TauRx

3 years

@TauRx and @GtDiagnostics symposium today, 1pm CET at @AlzheimerEurope #31AEC will reflect and discuss 'Late-stage clinical trial conduct during COVID-19: challenges, lessons, and the future for Alzheimer’s disease management.'

0

7

8

TauRx Therapeutics

@TauRx

3 years

Tau in healthy neurons are discussed in Tau and the Aging Brain Part 1 video from The Brain and Tau Pathology mini-series. View the full educational presentation here #targetingtau #timefortauisnow #dementia #alzheimers #tauprotein #educational

0

2

8

TauRx Therapeutics

@TauRx

3 years

@TauRx is Gold sponsor and will present at @AlzheimerEurope alongside @GtDiagnostics this week #31AEC . Visit our virtual stand and we look forward to meeting everyone. More here #targetingtau #timefortauisnow #dementia #clinicaltrials #diagnostics

TauRx Sponsor and Present at Alzheimer Europe 2021 - TauRx

TauRx is proud to be a Gold Sponsor of Alzheimer Europe 2021, where we will be presenting on clinical trial approaches.

taurx.com

0

6

8

TauRx Therapeutics

@TauRx

2 years

From 9-11 June, we’ll be attending the @AlzDisInt conference in London. The TauRx and @GTDiag teams look forward to exhibiting at the event and discussing our commitment to research in #dementia #ADI22 #Dementia #Alzheimers

1

3

8

TauRx Therapeutics

@TauRx

3 years

One week to go until #dementias2022 ! Our Chief Executive, Professor Claude Wischik will introduce a panel to discuss the question “How do we get to a system of effective diagnosis and treatment?” Read more about our tau-focused research

0

3

8

TauRx Therapeutics

@TauRx

4 years

"To be a small part of developing a treatment for Alzheimer's disease gives me a real sense of purpose." You can hear more from Dr Glenn Corr @TauRx here 👇 #dementia #Alzheimers #lifesciences #pharma #tau #targetingtau #tauprotein #timefortauisnow #taurx

0

3

7

TauRx Therapeutics

@TauRx

3 years

This year has been another difficult one for many and at @TauRx we’re grateful to have continued our important work to address Alzheimer’s disease. We’d like to thank everyone who has helped us progress. We hope you stay safe and well this Christmas.

0

2

8

TauRx Therapeutics

@TauRx

2 years

Hear from Senior Scientist, Lewis Penny, who recently represented us at @kemnayacademy Careers Fair: “It was a great opportunity to inspire the next generation to consider STEM careers and connect with parents on how they can help their children pursue these vital roles.” (1/3)

2

4

8

TauRx Therapeutics

@TauRx

1 year

For #media and #investors : TauRx announces our results from a prespecified analysis of our phase 3 trial. Read more: #AAIC23 #Alzheimers #clinicaltrials #tau #dementia

1

2

8

TauRx Therapeutics

@TauRx

3 years

Great first session on stroke and dementia. Now listening to @jean_tottie @tide_carers giving a carer's perspective #Dementias2021 @MAHealthEvents . So important to recognise the crucial value - £11.6bn per year - of unpaid care in the UK. The biggest workforce in dementia care.

0

6

8

TauRx Therapeutics

@TauRx

3 years

TauRx and GTD have given the Scottish Biologics Facility at the University of Aberdeen a £1m funding boost. This supports the continued development of a reliable diagnostic blood test enabling the early detection of Alzheimer’s Disease. Read more:

0

2

7

TauRx Therapeutics

@TauRx

4 years

TauRx aims to make a positive difference to the lives of patients, carers and families who are affected by neurodegenerative diseases. This is articulated by Claude Wischik as “Patients are the bedrock of everything we do"

0

3

8

TauRx Therapeutics

@TauRx

4 years

It has been a difficult year in so many ways. Thank you to everyone who has helped us progress our important #Alzheimers #tau #research this year despite such hurdles. Stay safe and well over the Christmas period and all the best for 2021 from everyone at TauRx.

0

2

7

TauRx Therapeutics

@TauRx

4 years

"TauRx is in itself really inspirational. What inspires me is the strong scientific background of the company. " Learn more from Sonya here #targetingtau #timefortauisnow #dementia #team #Alzheimers

0

1

8

TauRx Therapeutics

@TauRx

3 years

This #WorldAlzMonth @AlzDisInt is raising awareness of understanding dementia and to seek early diagnosis to #KnowDementia #KnowAlzheimers . View and download the warning signs of dementia here

0

3

8

TauRx Therapeutics

@TauRx

4 years

Members of the TauRx team are looking forward to getting together in Duthie Park, Aberdeen, on 20th September to support this event! @alzscot #Alzheimers #dementia #targetingtau

Alzheimer Scotland

@alzscot

4 years

It's only with your support that we can continue to be there for people in Scotland living with dementia, their families and their carers. Your route, your way, your Memory Walk Memory Walk Big Weekend💜Sat 19 & Sun 20 Sep Free registration 👉

0

3

4

0

7

TauRx Therapeutics

@TauRx

4 years

And very soon all the materials will be available for download! Thank you again @AlzheimerEurope for hosting us - we really enjoyed sharing our science with your members. #LetsTalkAboutDementia #targetingtau #tau

0

6

7

TauRx Therapeutics

@TauRx

2 years

Day 2 of #CTAD22 ! Our team are holding Q&A sessions and conducting in-person briefings to discuss our recent Phase 3 LUCIDITY trial results. If you’d like to meet with us, contact Jeff LaVaute at j.lavaute @taurx .com or +1 (908) 917-0443. #tau #Alzheimers #ClinicalTrials

0

1

7

TauRx Therapeutics

@TauRx

3 years

Next week at @AlzheimerEurope #31AEC , we’re discussing conducting late-stage clinical trials during COVID-19, outlining the challenges and lessons and touching on the future for #Alzheimers disease management #targetingtau #thetimefortauisnow #dementia

0

7

TauRx Therapeutics

@TauRx

5 years

This World Alzheimer’s Day, #LetsTalkAboutDementia

0

3

7

TauRx Therapeutics

@TauRx

4 years

#ADI2020 @AlzDisInt may be over but you can still visit @TauRx 3D booth and listen to our symposium until 12 January here ➡️

0

7

TauRx Therapeutics

@TauRx

4 years

Thank you for highlighting this important resource @AlzheimerEurope . Educational materials are suitable for all audiences, free to dowload, and include a comprehensive poster summarising tau pathology and treatment targets. #tau #targetingtau #Alzheimers

Alzheimer Europe

@AlzheimerEurope

4 years

@TauRx and BrainMind have a dedicated website about educational materials on the role of tau in #Alzheimer ’s disease

0

1

4

0

3

7

TauRx Therapeutics

@TauRx

2 years

It’s day two of #ADI2022 , where TauRx is a platinum sponsor. We’re enjoying meeting other industry experts passionate about finding a treatment for Alzheimer’s disease. Drop by and visit us at stand SO1 (Ground Floor Concourse): @ADIConference

0

4

7

TauRx Therapeutics

@TauRx

4 years

In the #BiotechShowcase @EBDgroup virtual conference Prof. Claude Wischik, CEO of @TauRx presents an update on the status of our LUCIDITY trial. Join us virtually, January 11–15, 2021 to watch our presentation. #BiotechShowcase #timefortauisnow #targetingtau #Alzheimers

0

7

TauRx Therapeutics

@TauRx

5 years

Congratulations to all TauRx staff whose dedication resulted in TauRx receiving the Technology Innovation Award in neurodegenerative disease management at @FrostSullivanAP Asia-Pacific Best Practices Awards last week.

1

7

TauRx Therapeutics

@TauRx

4 years

Dr Mohammad Arastoo @MoArastoo is an #EverydayScientist and #SmashingStereotypes . Hear more about what Dr Arastoo believes an everyday scientist is in this short video #BSW21

1

3

7

TauRx Therapeutics

@TauRx

5 years

Stigma is still a huge problem facing people living with Alzheimer’s. Help tackle this by taking part in the world’s largest survey by @AlzDisInt on people’s attitudes around dementia.

0

5

7

TauRx Therapeutics

@TauRx

1 year

This morning at AAIC, TauRx sponsored ‘Wake Up…It’s time for a new AD healthcare system!”, a panel discussion addressing programmes and services that could be implemented to evolve systems of care for Alzheimer’s and create a roadmap for lasting change:

0

3

7

TauRx Therapeutics

@TauRx

1 year

📣 We’re live at #AAIC23 ! We’re thrilled to be here and connect with leaders in #Alzheimers research. We presented new #clinicaltrial data this morning and are now busy networking with delegates and learning the latest in this research field. Visit us @GtDiagnostics stand 205!

0

3

7

TauRx Therapeutics

@TauRx

4 years

This week's @TauRx #TauFact all about tau in the healthy brain #dementia #Alzheimers #lifesciences #tau #tauprotein #timefortauisnow #targetingtau

0

3

7

TauRx Therapeutics

@TauRx

4 years

Very honest, informative and encouraging comments from @sme402 ( @AbdnCHDS ), @debsoneil ( @NovaBiotics ) and @CarolineBarelle ( @ElasmogenLtd ) this afternoon. There's much to look forward to in #lifesciences #Aberdeen . Thank you @Opportunity_NE1 for the session.

Opportunity North East (ONE)

@Opportunity_NE1

4 years

Looking forward to insights on NE Scotland's response to COVID-19 from @debsoneil ( @NovaBiotics ) @CarolineBarelle ( @ElasmogenLtd ) and @sme402 ( @AbdnCHDS & @GrampianDaSH ) at today's virtual #ONELifeSciences Network meeting #lifesciences #Aberdeen @LifeSciScot @BIA_UK

0

3

9

0

1

7

TauRx Therapeutics

@TauRx

4 years

The World Alzheimer Report 2021 Vital Clinicians Survey by @AlzDisInt is calling for doctors and clinicians globally to complete the survey. Deadline is today so please share widely.

ADI

@AlzDisInt

4 years

By understanding the current global picture around #dementia diagnosis, we can work to improve an often very difficult experience for millions of people. If you work in healthcare & are involved in the diagnosis process, it is vital that we hear from you:

2

16

24

0

3

7

TauRx Therapeutics

@TauRx

1 year

Prof. Claude Wischik first identified the Alzheimer’s disease tangle was composed of tau proteins over 30 years ago. Since then, our scientists have researched tau pathology in AD and other neurodegenerative diseases. To mark Dementia Awareness Week, hear about our research ⬇️

1

7

TauRx Therapeutics

@TauRx

4 years

Richie Lofthouse @Loft_PhD , final year PhD student is an #EverydayScientist and #SmashingStereotypes . Celebrate @ScienceWeekUK and hear more about Richie's view on what an everyday scientist is in the short video below. #BSW21 @SBF_ABDN

0

1

7

TauRx Therapeutics

@TauRx

2 years

Post-diagnostic support for people with dementia is centre stage this #WorldAlzMonth . We were honoured to present to members of the @AlzheimerEurope umbrella organisation, to provide an update on our clinical trial progress, tau pathology and therapeutic approaches.

1

2

7

TauRx Therapeutics

@TauRx

4 years

#ADI2020 is today! TauRx are excited to be sponsoring and presenting at this important conference. Come and visit our Virtual 3D booth and speak to members of our team to find out how TauRx are targeting #tau in #Alzheimer 's disease #dementia #research

0

1

7

TauRx Therapeutics

@TauRx

4 years

#Tau is a protein associated with many #brain diseases, including #Alzheimer 's. @TauRx believe #education is essential in spreading awareness and understanding of how tau and Alzheimer's disease are connected. Learn more here #targetingtau ➡️

1

7

TauRx Therapeutics

@TauRx

3 years

@TauRx is looking forward to attending and presenting with @DiagnosticsGt at @MAHealthEvents #Dementias2021 this week. Come and chat to us about #tau pathology, #diagnostics and #dementia at our stand and listen to Prof Wischik and Prof Schelter talk.

TauRx Supporting Dementias 2021 - TauRx Pharmaceuticals

TauRx and GT Diagnostics are sponsoring and will present at Dementias 2021 in London.

taurx.com

0

3

7

TauRx Therapeutics

@TauRx

4 years

Professor Tan Maw Pin @mawptan discusses the use of the @GTDiag HiPAL screening tool in Malaysian population. Hear more at our interactive #ADI2020 symposium Friday 11th December 12:50-13:50 and join our live Q&A session. #dementia #diagnostics #Alzheimers

0

1

7

TauRx Therapeutics

@TauRx

8 months

It’s almost time for #Dementias2024 ! As proud partners of this event, we look forward to connecting with fellow professionals to discuss how we can advance the diagnosis, treatment and care for those affected by Alzheimer’s disease and other dementias.

1

2

7

TauRx Therapeutics

@TauRx

4 years

Video 3 of @TauRx The Brain and Tau Pathology mini-series and this week Dr Sonya Miller, @TauRx Medical Oversight Lead narrates Tau and the Aging Brain Part 2. View the full educational presentation here 👇 #educational #dementia #alzheimers #tau

0

1

6

TauRx Therapeutics

@TauRx

6 years

September is World Alzheimer’s Month! Did you know that #Every3Seconds someone in the world develops dementia, which is why ongoing research is so crucial #WorldAlzMonth

0

7

6

TauRx Therapeutics

@TauRx

6 years

The FDA has granted orphan drug designation to TauRx’s LMTX in frontotemporal dementia. Click here to read the full press release:

0

5

6

TauRx Therapeutics

@TauRx

4 years

We are very much looking forward to this event @AlzDisInt , and pleased to be sponsoring #ADI2020 . The time for tau is now... #tau #AlzheimersDisease

ADI

@AlzDisInt

4 years

There is just one month until ADI's 34th Virtual International Conference #ADI2020 . Join us and 1000 delegates for a packed programme over 3 days, viewable for 1 month afterwards. Find out more & register:

0

9

11

0

7

TauRx Therapeutics

@TauRx

2 years

We’re excited to join fellow industry experts at @ADIConference #ADI2022 . Hear about our research targeting tau in #Alzheimer ’s disease and join our Head of Medical Affairs and Medical Oversight Lead, Dr Sonya Miller for a fireside chat on patient impact:

0

2

7

TauRx Therapeutics

@TauRx

4 years

The future of #Alzheimer 's disease #diagnostics in primary care is hopeful. Watch Professor Claude Wischik, Professor Bjoern Schelter, and Dr. Serge Gauthier discuss this important topic ➡️

0

2

6

TauRx Therapeutics

@TauRx

7 months

TauRx has been making progress towards new approaches for people affected by neurodegenerative diseases for decades – the presentation of this data is an important milestone in this journey. Learn more about our latest data on @BioSpace :

Two Year Sustained Cognitive Benefits of Hydromethylthionine Mesylate (HMTM) Indicated by TauRx's...

TauRx Pharmaceuticals Ltd., a global leader in tau-based research in Alzheimer’s disease (AD), presented the 24-month data from its Phase 3 LUCIDITY trial of hydromethylthionine mesylate (HMTM) at...

www.biospace.com

1

3

6

TauRx Therapeutics

@TauRx

3 years

At @TauRx , we’re pioneering #tau -based research and our mission is to discover and develop innovative ways to diagnose and treat the neurodegenerative diseases caused by this protein. Learn more here #targetingtau #timefortauisnow #dementia #alzheimers

0

2

6

TauRx Therapeutics

@TauRx

4 years

Thank you @Opportunity_NE1 - we're in unprecedented times, but rising to the challenge to maintain progress in our research and LUCIDITY trial. @AlzDisInt @ITNProductions #Alzheimers #dementia #targetingtau

Opportunity North East (ONE)

@Opportunity_NE1

4 years

Aberdeen-based @TauRx is a leader in Alzheimer's disease research on a mission to discover, develop & commercialize innovative products to diagnose, treat & cure neurodegenerative diseases @AlzDisInt @ITNProductions #lifesciences #Aberdeen #dementia

0

2

4

0

6

TauRx Therapeutics

@TauRx

9 months

Welcome to 2024! It’s set to be another busy year as we continue to progress our mission to develop innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation. Follow us to stay up to date!

2

0

4

TauRx Therapeutics

@TauRx

3 years

@TauRx is delighted to be presenting at the #ONELifeSciencesNetwork @Opportunity_NE1 today. It is a chance to discuss our work in #dementia and #Alzheimers and what better day to discuss this than #WorldAlzDay ! #targetingtau #timefortauisnow #KnowDementia #KnowAlzheimers

0

6

TauRx Therapeutics

@TauRx

3 years

Read more about the work being done in Scotland to tackle dementia, and progress brain health @TheScotsman , @brainhealthscot @craig_ritchie68 #targetingtau #timefortauisnow #Alzheimers #dementia #tauprotein

TauRx Feature in The Scotsman Article - TauRx

TauRx’s expertise in tau protein pathology is highlighted in The Scotsman’s latest sponsored article ‘What does the future of brain health look like?’ Learn more today.

taurx.com

0

2

6

TauRx Therapeutics

@TauRx

4 years

@TauRx is celebrating British Science Week @ScienceWeekUK . Dr Helen Shiells is an #EverdayScientist and is #SmashingStereotypes . Hear more about Dr Shiells work in this short video. #BSW21

0

1

5

TauRx Therapeutics

@TauRx

4 years

The line 1 modelling reproduced cholinergic deficit of AD, and was used to reproduce the interference with hydromethylthionine treatment effects that result from prior anticholinesterase therapy in AD trials. This supports our current phase 3 #Alzheimers trial as monotherapy.

@BrainComms

@braincomms

4 years

Cranston et al. just published in @braincomms their work about "Cholinergic and inflammatory phenotypes in transgenic tau mouse models of #AlzheimersDisease and Frontotemporal Lobar Degeneration". Read it 📚at @aberdeenuni @nencki @TauRx @ChariteBerlin

0

8

14

0

3

6

TauRx Therapeutics

@TauRx

1 year

Did you know our Executive Chairman and Co-founder Professor Claude Wischik helped discover the role of tau protein in Alzheimer’s? But what is tau and how can it cause Alzheimer’s? Our Head of Medical Affairs, Dr Sonya Miller explains ⬇️

0

6

TauRx Therapeutics

@TauRx

4 years

"Working for TauRx inspires me because of the importance of the mission and the nature of the people. Dementia is the world's greatest unmet medical need and I have felt the devastating impact of it." Here more from Dr Glenn Corr, @TauRx COO here 👇

0

1

5

TauRx Therapeutics

@TauRx

3 years

Today's #TauFacts . You can view our dedicated educational materials here #targetingtau #timefortauisnow #dementia #alzheimers #tauprotein #tau

0

2

6

TauRx Therapeutics

@TauRx

2 years

We’re excited to join fellow industry experts at @alzassociation #AAIC22 this week. We’re at exhibition business suite #E0 - make sure to drop by to chat to the team and learn more about our work. Can’t attend the conference? Read about our research:

0

1

6

TauRx Therapeutics

@TauRx

3 years

Ahead of the @AlzDisInt Diagnostics webinar which will feature @GtDiagnostics amongst others. You can learn more about @GtDiagnostics in the video below. Sign up to the webinar here #dementia #Alzheimers #diagnostics

0

6

TauRx Therapeutics

@TauRx

4 years

Great that the #ADI2020 material will be available to view until 12th January. Plenty of time to visit and view the materials at the TauRx virtual booth! #tau #targetingtau #Alzheimers #dementia

ADI

@AlzDisInt

4 years

Did you know that you can view #ADI2020 poster presentations & exhibitions at any time? Be sure to check out the vast array of interesting content on the conference platform, available to view until 12 January.

2

4

16

0

3

6

TauRx Therapeutics

@TauRx

4 years

Dr Sonya Miller, @TauRx Medical Oversight Lead, features in the second of our Meet the Team series. Dr Miller talks about working for @TauRx and a hope for the future of Alzheimer's disease treatment. Watch below or here ➡️ #dementia #Alzheimers #tau

1

5

TauRx Therapeutics

@TauRx

4 years

Happy New Year from TauRx. We hope 2021 brings yet more significant industry advances in #research . We'll continue our commitment to a tau-focused treatment for #Alzheimers and #neurodegenerative diseases. Look out for news, updates, events and videos. The time for #tau is now!

0

2

5

TauRx Therapeutics

@TauRx

2 years

#DidYouKnow dementia is one of the UK's leading causes of death? We’re looking forward to #WorldAlzMonth to raise awareness and amplify the voice of those affected by Alzheimer’s disease. Stay tuned to find out how we’re showing our support for the campaign. @AlzDisInt

0

6

TauRx Therapeutics

@TauRx

4 years

Our mission is to discover and develop innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through tau protein aggregation

0

6

TauRx Therapeutics

@TauRx

4 years

Excited to soon launch @TauRx Meet the Team series! First up 👉Dr Glenn Corr, COO, who joined July 2020. Below is a teaser. Watch out for the video this Friday 29th Jan. #lifesciences #tau #tauprotein #targetingtau #timefortauisnow #dementia #Alzheimers #team #video

0

3

6

TauRx Therapeutics

@TauRx

4 years

Please do ask us if you have questions about our trial, or our research. We love to talk about it, and remain committed to making progress despite such challenging conditions at present. Thank you @AlzDisInt for highlighting our work. #dementia #targetingtau #Alzheimer

ADI

@AlzDisInt

4 years

Clinical trials are vital in finding solutions for #dementia and other #NCDs . See how pharmaceutical company @TauRX is carrying out clinical trials to find answers in ‘Hope in the Age of Dementia,’ our news-style programme with @ITNProductions .

0

4

8

0

3

6

TauRx Therapeutics

@TauRx

3 years

@TauRx is a company with decades of research focusing on tau pathology, going against the mainstream. Prof. Claude Wischik CEO @TauRx gave some advice for scientists at @UCLNeuroSoc presentation. #timefortauisnow #targetingtau #Alzheimers #dementia

0

3

6